Soparkar Peter 4
4 · Adverum Biotechnologies, Inc. · Filed Dec 8, 2025
Insider Transaction Report
Form 4
Soparkar Peter
CHIEF OPERATING OFFICER
Transactions
- Purchase
Common Stock
2025-12-05$4.22/sh+50,000$211,000→ 80,189 total
Footnotes (2)
- [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.18 to $4.24. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 600 shares purchased on May 21, 2025, and 600 shares purchased on November 20, 2025, pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.